Glen Spraggon

This inventor holds 11 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Novartis Ag, Irm LLC, Novartis Institute for Functional Genomics, Inc., Dba Genomics Institute of the Novartis Research Foundation. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glen Spraggon. Retrieved from https://idiyas.com/inventor/glen-spraggon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 72.7

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

Novartis Institute for Functional Genomics, Inc., Dba Genomics Institute of the Novartis Research Foundation

patent

Years Active: 2011-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691181 - METHODS OF TREATMENT OF CANCER WITH ANTIBODY-IL-2 ENGRAFTED PROTEINS (2026-07-28),

2. 12180291 - Anti-CCR7 antibody drug conjugates (2024-12-31),

3. 12006354 - Antibody-IL2 engrafted proteins and methods of use in the treatment of cancer (2024-06-11),

4. 11930837 - Antibody-cytokine engrafted proteins and methods of use for immune related disorders (2024-03-19),

5. 11634497 - Anti-CCR7 antibody drug conjugates (2023-04-25),

6. 11136366 - Methods of treating immune related disorders using antibody-cytokine engrafted compositions (2021-10-05),

7. 11122825 - Antibody-cytokine engrafted proteins and methods of use for immune related disorders (2021-09-21),

8. 10144768 - Antibody cytokine engrafted compositions and methods of use for immunoregulation (2018-12-04),

9. 8338469 - Compounds and compositions as channel activating protease inhibitors (2012-12-25),

10. 7951823 - Compounds and compositions as channel activating protease inhibitors (2011-05-31),

11. 7939547 - Compounds and compositions as channel activating protease inhibitors (2011-05-10),

Title: Glen Spraggon - Innovative Inventor from San Diego

Introduction: Glen Spraggon is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Glen Spraggon holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Glen Spraggon has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Glen Spraggon has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Glen Spraggon's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and beyond.

Profile summary based on public USPTO records.